Deutsche Bank’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
Other funds holding CASI
CCM
IACGFIA
WSCM
WSC
IC
Deutsche Bank's CASI Position: Q2 2021 in Review
Deutsche Bank sold out of CASI Pharmaceuticals (CASI) in Q2 2021, closing a stake of 4,427 shares — an estimated $106K sold.
Deutsche Bank first reported a position in CASI in Q3 2013 and held it in 20 quarters. The position peaked at $805K in Q2 2018. 68 funds tracked by Wall St. Rank hold CASI as of Q2 2021.
- Deutsche Bank reported no remaining CASI Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 4,427 CASI Pharmaceuticals shares in Q2 2021, an estimated $106K.
- Deutsche Bank first reported a position in CASI Pharmaceuticals in Q3 2013 and held it in 20 quarters.
- Deutsche Bank's CASI Pharmaceuticals position peaked at $805K in Q2 2018.
- 68 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.